Table 4 Individual serum bicarbonate values for each participant at baseline and post-ingestion
Participant # | Condition | Baseline (mmol·L− 1) | Post-ingestion (mmol·L− 1) | Change from Baseline (mmol·L− 1) | Change from Baseline (%) | Change Compared to Placebo (mmol·L− 1) |
|---|---|---|---|---|---|---|
1 | Placebo | 26.4 | 29.4 | 3.0 | 11% | |
AcuteSB | 30.0 | 35.6 | 5.7 | 19% | 2.6 | |
ModSB | 23.2 | 37.1 | 13.9 | 60% | 10.9 | |
2 | Placebo | 27.7 | 29.6 | 1.9 | 7% | |
AcuteSB | 28.7 | 34.5 | 5.8 | 20% | 3.9 | |
ModSB | 28.2 | 34.7 | 6.4 | 23% | 4.5 | |
3 | Placebo | 30.9 | 32.3 | 1.4 | 5% | |
AcuteSB | 28.3 | 30.8 | 2.5 | 9% | 1.1 | |
ModSB | 30.3 | 32.0 | 1.7 | 6% | 0.3 | |
4 | Placebo | 28.0 | 30.1 | 2.1 | 7% | |
AcuteSB | 27.2 | 36.1 | 8.9 | 33% | 6.8 | |
ModSB | 28.3 | 35.0 | 6.7 | 24% | 4.6 | |
5 | Placebo | 23.1 | 27.7 | 4.6 | 20% | |
AcuteSB | 26.8 | 33.5 | 6.7 | 25% | 2.1 | |
ModSB | 26.1 | 37.9 | 11.8 | 45% | 7.2 | |
6 | Placebo | 27.1 | 29.7 | 2.6 | 10% | |
AcuteSB | 26.6 | 32.7 | 6.1 | 23% | 3.5 | |
ModSB | 26.6 | 34.4 | 7.8 | 29% | 5.2 | |
7 | Placebo | 26.8 | 29.5 | 2.8 | 10% | |
AcuteSB | 26.6 | 31.3 | 4.7 | 18% | 2.0 | |
ModSB | 27.0 | 32.1 | 5.1 | 19% | 2.3 |